Omega Fund IV, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Omega Fund IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Omega Fund IV, L.P.. Omega Fund IV, L.P. is a in Kezar Life Sciences, Inc. ($KZR) and a 10% Owner in Translate Bio, Inc. ($TBIO) and a 10% Owner in Replimune Group, Inc. ($REPL) and a Director in Replimune Group, Inc. ($REPL).
Address: 1 ROYAL PLAZA, ROYAL AVENUE ST. PETER PORT GY1 2HL Y7
Companies in which Omega Fund IV, L.P. is an Insider
Kezar Life Sciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Omega Fund IV, L.P.:
Holdings: 315,489 shares
Latest Transaction: Jun 25 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Omega Fund IV, L.P.: Director, 10% Owner
Holdings: 5,141,321 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Translate Bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Omega Fund IV, L.P.: 10% Owner
Holdings: 979,179 shares
Latest Transaction: Jul 03 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Omega Fund IV, L.P.
Sentiment: All, KZR, REPL, TBIO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
| Feb 11 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | 10% Owner | Sell | S | 45.00 | 5,249 | 236,205 | 5,141,321 | 5.1 M to 5.1 M (-0.10 %) |
| Jan 28 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 46.04 | 3,393 | 156,214 | 5,283,682 | 5.3 M to 5.3 M (-0.06 %) |
| Jan 28 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.34 | 26,957 | 1,222,230 | 5,287,075 | 5.3 M to 5.3 M (-0.51 %) |
| Jan 26 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.03 | 3,269 | 147,203 | 5,314,032 | 5.3 M to 5.3 M (-0.06 %) |
| Jan 26 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.05 | 8,090 | 364,455 | 5,317,301 | 5.3 M to 5.3 M (-0.15 %) |
| Jan 19 2021 | REPL | Replimune Group, I ... | Omega Fund IV, L.P. | Director | Sell | S | 45.19 | 1,916 | 86,584 | 5,325,391 | 5.3 M to 5.3 M (-0.04 %) |